Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Evonik
Evonik
Activities:
Ingredients
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Drug Delivery
Evonik begins construction on pharmaceutical lipids facility
The centre will be built on the grounds of Evonik Tippecanoe Laboratories and scheduled to go "onstream" in 2025
Infection Control
Evonik launches plant-based squalene to boost vaccine efficacy
It meets the demand for a secure commercial supply of non-animal-derived squalene
Packaging
Evonik wins CPHI Excellence award for "Packaging and Drug Delivery"
The award was presented at the CPHI pharmaceutical trade show in Frankfurt on November 1, 2022
Finance
Evonik introduces three product lines for health care business
This structural shift is aimed to further transitions the health care business line into a system solutions partner for the pharmaceutical and biotech industries
Manufacturing
Evonik invests in 3D printed tablet tech for controlled delivery
Laxxon Medical’s 3D screen printing technology allows tablets to be constructed in layers of API or inert ingredients
Manufacturing
Evonik increases plant-derived cholesterol supply
The ingredient is used in the manufacture of mRNA vaccines and gene therapies
Manufacturing
Evonik launches updated extruder for liposomal drug manufacturing
LIPEX Flow supports the scale-up of processes from drug discovery through to GMP at lab, pilot, intermediate and commercial-scale volumes
Subscribe now